| LINE ITEM (USD / %) | FY 2025
FILED 2025-07-31 | FY 2024
FILED 2024-07-31 | FY 2023
FILED 2023-07-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.96B | $2.89B | $2.89B |
| YoY Revenue Growth % | +2.7% | -0.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $560.0M | $488.8M | $504.4M |
| Operating Margin % | 18.9% | 16.9% | 17.5% |
| Net Income (GAAP) | $298.0M | $246.3M | $285.1M |
| EBITDA (Normalized) | $666.7M | $592.7M | $608.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $554.9M | $589.0M | $637.9M |
| Capital Expenditures (CapEx) | $133.4M | $129.8M | $130.0M |
| Free Cash Flow (FCF) | $421.5M | $459.2M | $507.8M |
| FCF Margin % | 14.2% | 15.9% | 17.6% |
| Return on Invested Capital (ROIC %) | 20.6% | 18.0% | 19.0% |
| Cash & Short-Term Equivalents | $384.7M | $488.2M | — |
| Total Debt (Short + Long Term) | $2.23B | $2.12B | $811.3M |
| Total Stockholders' Equity | $301.8M | $515.5M | $1.66B |